Sphera Funds Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-198,880
Closed -$3.82M 104
2021
Q3
$3.82M Buy
+198,880
New +$2.64M 0.32% 76
2016
Q1
Sell
-90,000
Closed -$2.17M 99
2015
Q4
$2.17M Sell
90,000
-10,000
-10% -$250K 0.32% 79
2015
Q3
$2.45M Sell
100,000
-50,000
-33% -$1.42M 0.31% 81
2015
Q2
$3.51M Buy
+150,000
New +$3.27M 0.34% 69

Other funds holding DVAX

Sphera Funds Management's DVAX Position: Q4 2021 in Review

Sphera Funds Management sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 198,880 shares — an estimated $3.82M sold.

Sphera Funds Management first reported a position in DVAX in Q2 2015 and held it in 4 quarters. The position peaked at $3.82M in Q3 2021. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

  • Sphera Funds Management reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
  • Sphera Funds Management sold 198,880 Dynavax Technologies shares in Q4 2021, an estimated $3.82M.
  • Sphera Funds Management first reported a position in Dynavax Technologies in Q2 2015 and held it in 4 quarters.
  • Sphera Funds Management's Dynavax Technologies position peaked at $3.82M in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.